Tag: oncohost

[OncoHost in BioSpace] OncoHost and RayBiotech Awarded $1 Million Grant From the BIRD Foundation to Advance Precision Oncology for Patients Receiving Immunotherapy

OncoHost, global leader in host response profiling for improved personalized cancer therapy, together with its partner RayBiotech, a leading life sciences company developing high-throughput protein detection technologies for biomarker discovery initiatives, announced today the companies have been awarded a $1 million grant from the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation. Read...

Read More

[OncoHost in Jerusalem Post] Israeli algorithm may predict if cancer patients will respond to treatment

“Profiling of host response to immunotherapy addresses a major challenge in oncology today – understanding why treatment helps some patients but not others,” said Dr. Ofer Sharon, CEO of OncoHost. “By combining OncoHost’s proprietary technology with proteomic analysis (the large-scale study of proteins), we are able to predict how individual patients may respond to treatment. This is the first step towards developing successful personalized cancer treatment plans.” Read...

Read More

Latest from Twitter